Jeffrey Crawford, MD

Jeffrey Crawford, MD, is the George Barth Geller Professor for Research in Cancer and lead principal investigator (PI) of National Clinical Trials Network (NCTN) LAPS Grant in the Duke Cancer Institute in Durham, NC. He earned his medical degree from Ohio State University and completed his internship, residency, and hematology/oncology fellowship at Duke University Medical Center. Dr Crawford served as chief of the Division of Medical Oncology for 10 years prior to assuming his current leadership roles. He also served as chair of the National Comprehensive Cancer Network Myeloid Growth Factors Panel for 15 years.

Dr Crawford’s research interests include new treatment approaches to lung cancer, supportive care therapies including hematopoietic growth factors and biosimilars, and agents that impact muscle wasting. He has published more than 250 manuscripts, chapters, and reviews.